Overview
- 85 inspections across 85 sites are on record.
- 122 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-03-06.
At a glance
Inspections
85
Sites
85
Observations
122
Career since
Dec 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Millicent Pharma (NI) Limited | 6 Mar 2026 | Human Drugs | On file |
| Nicobrand Limited | 27 Feb 2026 | Human Drugs | On file |
| Orean Personal Care Ltd | 20 Feb 2026 | Human Drugs | On file |
| Granules Life Sciences Private Limited | 19 Dec 2025 | Human Drugs | On file |
| Dr Reddy's Laboratories Limited | 12 Dec 2025 | Human Drugs | On file |
Sites inspected
Millicent Pharma (NI) LimitedLarne, United Kingdom1 insp.
Nicobrand LimitedColeraine, United Kingdom1 insp.
Orean Personal Care LtdCleckheaton, United Kingdom1 insp.
Granules Life Sciences Private LimitedMalkajgiri, India1 insp.
Dr Reddy's Laboratories LimitedDevunipalavalasa, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Dipesh K Shah5 shared
Amy N Chen3 shared
Eileen A Liu3 shared
Saleem A Akhtar3 shared
Suzanne N Vallez2 shared
Wenzheng Zhang2 shared
Thomas J Arista2 shared
Juan R Jimenez Garcia2 shared
Robert J Veitch2 shared
Dorothy P Kramer1 shared
Full investigator report
Get the verbatim findings behind Rajiv R Srivastava's 122 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site